Journal of Cholesterol and Heart Disease

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Mini Review - Journal of Cholesterol and Heart Disease (2023) Volume 7, Issue 4

Microvascular Abnormalities and Hemodynamic Alterations in Arteriovenous Fistulas and Malformations

Budoff Chris *

Department of Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy

*Corresponding Author:
Budoff Chris
Department of Dialysis and Transplantation
San Bortolo Hospital
Vicenza, Italy
E-mail: chrisbudoff@yahoo.com

Received: 01-Aug-2023, Manuscript No. AACHD-23-112279; Editor assigned: 03-Aug-2023, PreQC No. AACHD-23-112279 (PQ); Reviewed: 17-Aug-2023, QC No. AACHD -23-112279; Revised: 21-Aug-2023, Manuscript No. AACHD-23-112279 (R); Published: 28-Aug-2023, DOI: 10.35841/aachd-7.4.163

Citation: Chris B. Microvascular abnormalities and hemodynamic alterations in arteriovenous fistulas and malformations. J Cholest Heart Dis 2023;7(4):163

Visit for more related articles at Journal of Cholesterol and Heart Disease

Introduction

Arteriovenous fistulas (AVFs) and malformations (AVMs) are vascular anomalies characterized by abnormal connections between arteries and veins. These conditions can result in significant microvascular abnormalities and hemodynamic alterations, leading to clinical manifestations ranging from cosmetic concerns to life-threatening complications. This article provides an in-depth review of the microvascular abnormalities and hemodynamic alterations associated with AVFs and AVMs, focusing on their underlying mechanisms, diagnostic approaches, and therapeutic implications [1].

Arteriovenous fistulas and malformations are congenital or acquired vascular anomalies characterized by direct connections between arteries and veins, bypassing the normal capillary bed. These abnormal vascular communications disrupt the natural hemodynamic balance, resulting in microvascular abnormalities and altered blood flow dynamics. Understanding the underlying mechanisms and consequences of these microvascular abnormalities and hemodynamic alterations is crucial for accurate diagnosis, risk assessment, and effective management of AVFs and AVMs [2].

 

Microvascular abnormalities in AVFs and AVMs encompass a spectrum of structural and functional changes within the affected vascular bed. Dilated and tortuous vessels, arteriovenous shunting, microaneurysms, and abnormal capillary networks are among the common manifestations. These abnormalities are a result of altered vascular remodeling, endothelial dysfunction, and dysregulated angiogenesis. The presence of abnormal microvasculature contributes to tissue hypoxia, impaired tissue perfusion, and altered metabolic demands, which can lead to tissue ischemia, organ dysfunction, and secondary complications.mThe presence of AVFs and AVMs disrupts the normal hemodynamic balance by creating high-flow arteriovenous shunts. Hemodynamic alterations include increased blood flow velocity, elevated arterial pressure, turbulent flow patterns, and altered shear stress within the abnormal vascular connections. These alterations can lead to endothelial damage, inflammation, and thrombosis. Additionally, the hemodynamic burden on the heart and surrounding vasculature may result in cardiac overload, heart failure, and vascular remodeling [3,4].

 

Accurate diagnosis of AVFs and AVMs requires a combination of clinical evaluation, imaging modalities, and hemodynamic assessments. Various non-invasive and invasive imaging techniques, such as ultrasound, magnetic resonance imaging (MRI), computed tomography angiography (CTA) and catheter-based angiography, are employed to visualize the vascular anatomy, identify microvascular abnormalities, and evaluate hemodynamic parameters. Advanced imaging techniques, such as 4D flow MRI and micro-ultrasound, offer valuable insights into the complex hemodynamics of AVFs and AVMs. Treatment strategies for AVFs and AVMs aim to restore normal hemodynamics, relieve symptoms, and prevent complications. Therapeutic options include embolization, surgical resection, radiosurgery, and targeted pharmacotherapy. Selecting the appropriate treatment approach depends on several factors, including the anatomical characteristics, clinical presentation, and associated complications. Furthermore, advancements in endovascular techniques and personalized medicine approaches hold promise for improving outcomes and reducing the risk of recurrence [5].

References

  1. Mossa-Basha M, Chen J, Gandhi D. Imaging of cerebral arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin. 2012;23(1):27-42.

    2. Indexed at, Google Scholar, Cross Ref

  2. Crotty KL, Orihuela E, Warren MM. Recent advances in the diagnosis and treatment of renal arteriovenous malformations and fistulas. J Urol. 1993;150(5):1355-9.

    3. Indexed at, Google Scholar, Cross Ref

  3. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg. 1995;82(2):166-79.

    4. Indexed at, Google Scholar, Cross Ref

  4. Cho WS, Kim KJ, Kwon OK, et al. Clinical features and treatment outcomes of the spinal arteriovenous fistulas and malformations. J Neurosurg: Spine. 2013;19(2):207-16.

    5. Indexed at, Google Scholar, Cross Ref

  5. Le TT, Fischbein NJ, Andre JB, Wijman C, et al. Identification of venous signal on arterial spin labeling improves diagnosis of dural arteriovenous fistulas and small arteriovenous malformations. Am J Neuroradiol. 2012;33(1):61-8.

    6. Indexed at, Google Scholar, Cross Ref

Get the App